TP53 and neoplasm: For comparison with EPHA2, we simultaneously performed amplicon sequencing of the gene coding for cellular tumor antigen p53 (TP53)—a tumor suppressor gene that is known to acquire somatic mutations in several cancers (e.g. cutaneous melanoma) (http://cancer.sanger.ac.uk/cosmic).